![Benjamin Qiu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benjamin Qiu currently works at Ablaze Pharmaceuticals, as Director and Advantech Advisors (HK) Limited, as Partner.
| Sociétés | Poste | Début |
|---|---|---|
Ablaze Pharmaceuticals
 Ablaze Pharmaceuticals Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of radiopharmaceutical therapies to treat cancer patients | Directeur/Membre du Conseil | - |
Advantech Advisors (HK) Limited
 Advantech Advisors (HK) Limited Investment ManagersFinance Advantech Advisors invests in companies located in China. The firm focuses on tmt & e-services and healthcare sectors. It participates in growth stage transactions with an investment size of USD 560 million. | Private Equity Investor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Advantech Advisors (HK) Limited
Advantech Advisors (HK) Limited Investment ManagersFinance Advantech Advisors invests in companies located in China. The firm focuses on tmt & e-services and healthcare sectors. It participates in growth stage transactions with an investment size of USD 560 million. | Finance |
Ablaze Pharmaceuticals
Ablaze Pharmaceuticals Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of radiopharmaceutical therapies to treat cancer patients | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
